Neurocardiogenic syncope epidemiology and demographics

Neurocardiogenic Syncope Microchapters
Home
Patient Info
Overview
Pathophysiology
Epidemiology and Demographics
Risk Factors
Causes
Natural History, Complications & Prognosis
Differentiating Neurocardiogenic Syncope From Other Diseases
Diagnosis
History & Symptoms
Physical Examination
Tilt Table Testing
Treatment
Pharmacotherapy
Pacemaker therapy
Neurocardiogenic syncope epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Neurocardiogenic syncope epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Neurocardiogenic syncope epidemiology and demographics
CDC on Neurocardiogenic syncope epidemiology and demographics
Neurocardiogenic syncope epidemiology and demographics in the news
Blogs on Neurocardiogenic syncope epidemiology and demographics
Directions to Hospitals Treating Neurocardiogenic Syncope
Risk calculators and risk factors for Neurocardiogenic syncope epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Neurocardiogenic syncope is the most common cause of syncope in children and adults and accounts for approximately 10-40% of all syncopal episodes.

Incidence

The prevalence is 22% in the general population. Approximately 50%-66% of syncope cases are classified as due to vasovagal syncope.

References

Template:WikiDoc Sources